Yi-Tung Tom Huang
Research Subjects
Yi-Tung Tom Huang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Michael Lin
Department of Nuclear Medicine and PET, Sydney, Australia
2 shared publicationsA S. Ravi Kumar
1 shared publication- Alan Coulthard
Department of Medical Imaging Royal Brisbane and Women's Hospital Brisbane Queensland Australia
1 shared publication Aravind S. Ravi Kumar
1 shared publication- Aravind S. Ravi Kumar1 shared publication
- Calvin Joomann Park
Neurogastroenterology Unit and Department of Gastroenterology Royal North Shore Hospital St Leonards New South Wales Australia
1 shared publication
Latest Publications
- 25 July 2016
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 13 (5) , e262-e270
The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis
Semiquantitative PET variables are potentially valuable prognostic biomarkers in CRLM. Volumetric data like metabolic tumor volume enable better estimation of tumor burden and its utility may improve preoperative risk stratification and optimize outcome.
- 25 July 2016
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 13 (5) , e262-e270
The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis
Semiquantitative PET variables are potentially valuable prognostic biomarkers in CRLM. Volumetric data like metabolic tumor volume enable better estimation of tumor burden and its utility may improve preoperative risk stratification and optimize outcome.
- 1 March 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (3) , e167-e168
Rectal Carcinoma on 68Ga-PSMA PET/CT
We report on a case of biopsy-proven and MRI-staged rectal carcinoma with avid prostate-specific membrane antigen (prostate-specific membrane antigen) uptake on Ga PET/CT as part of the workup for synchronous prostate cancer. This case adds to the growing number of observational reports on the presence of significant nonprostatic prostate-specific membrane antigen activity in malignant tumors and highlights the need for careful interpretation of unsuspected sites.
- 1 March 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (3) , e167-e168
Rectal Carcinoma on 68Ga-PSMA PET/CT
We report on a case of biopsy-proven and MRI-staged rectal carcinoma with avid prostate-specific membrane antigen (prostate-specific membrane antigen) uptake on Ga PET/CT as part of the workup for synchronous prostate cancer. This case adds to the growing number of observational reports on the presence of significant nonprostatic prostate-specific membrane antigen activity in malignant tumors and highlights the need for careful interpretation of unsuspected sites.
- 1 May 2015
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 40 (5) , e287-e289
Detection of Synchronous Gastric Schwannoma on FDG PET/CT Aided by Discordant Metabolic Response
This is a case of an unsuspected synchronous gastric schwannoma demonstrating increased F-FDG accumulation on PET/CT in a 65-year-old female patient diagnosed with non-Hodgkin lymphoma on the basis of different metabolic activity to other sites of disease at staging and discordant metabolic response to therapy. The gastric schwannoma was confirmed by histopathology and immunohistochemistry after surgical resection. This case adds to the limited literature on FDG-avid gastric schwannoma and highlights the importance of investigating differential metabolic activity and response on serial PET/CT imaging.
- 1 May 2015
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 40 (5) , e287-e289
Detection of Synchronous Gastric Schwannoma on FDG PET/CT Aided by Discordant Metabolic Response
This is a case of an unsuspected synchronous gastric schwannoma demonstrating increased F-FDG accumulation on PET/CT in a 65-year-old female patient diagnosed with non-Hodgkin lymphoma on the basis of different metabolic activity to other sites of disease at staging and discordant metabolic response to therapy. The gastric schwannoma was confirmed by histopathology and immunohistochemistry after surgical resection. This case adds to the limited literature on FDG-avid gastric schwannoma and highlights the importance of investigating differential metabolic activity and response on serial PET/CT imaging.
- 1 May 2012
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 33 (5) , 503-508
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma
Background Fluorine-18 fluorodeoxyglucose PET/computed tomography (CT) is now routinely used for staging and monitoring treatment response in head and neck squamous cell carcinoma (HNSCC). Although most patients with HSNCC have locoregional disease, distant metastases are relatively uncommon and occur predominantly in the lungs. Aim To explore the potential of a limited scan range from the skull vertex to lung bases, viz. an ‘above diaphragm’ scan, as an adequate examination for assessment of disease following chemoradiotherapy. Methods A retrospective review of 240 patients with HNSCC both staged and monitored after therapy with 18F-fluorodeoxyglucose PET/CT was conducted. Patients with previous HNSCC, unknown primary and known distant metastatic disease were excluded. Patients with positive PET/CT findings below the neck on the posttherapy study were confirmed on either follow-up clinical or radiological findings. Results A total of 196 (81.7%) patients had nodal disease at PET/CT staging. Unrelated findings were present in 50 (20.8%) patients, including five colonic neoplasms and two second malignancies. After an average of 6.4 months after staging, 13 patients (5.4%) demonstrated progression to distant metastases on the posttherapy PET/CT. All patients demonstrated intrapulmonary metastases. Two patients had additional liver metastases, which would not have impacted on the overall management. No patient demonstrated isolated disease below the diaphragm. Conclusion A limited ‘above-diaphragm’ scan for early assessment following chemoradiotherapy may be safely considered. The benefits of this tailored approach flow onto both the health system and the patients as it can improve resource allocation by increasing scanner availability and patient throughput and reduces cumulative patient radiation exposure.
- 1 May 2012
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 33 (5) , 503-508
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma
Background Fluorine-18 fluorodeoxyglucose PET/computed tomography (CT) is now routinely used for staging and monitoring treatment response in head and neck squamous cell carcinoma (HNSCC). Although most patients with HSNCC have locoregional disease, distant metastases are relatively uncommon and occur predominantly in the lungs. Aim To explore the potential of a limited scan range from the skull vertex to lung bases, viz. an ‘above diaphragm’ scan, as an adequate examination for assessment of disease following chemoradiotherapy. Methods A retrospective review of 240 patients with HNSCC both staged and monitored after therapy with 18F-fluorodeoxyglucose PET/CT was conducted. Patients with previous HNSCC, unknown primary and known distant metastatic disease were excluded. Patients with positive PET/CT findings below the neck on the posttherapy study were confirmed on either follow-up clinical or radiological findings. Results A total of 196 (81.7%) patients had nodal disease at PET/CT staging. Unrelated findings were present in 50 (20.8%) patients, including five colonic neoplasms and two second malignancies. After an average of 6.4 months after staging, 13 patients (5.4%) demonstrated progression to distant metastases on the posttherapy PET/CT. All patients demonstrated intrapulmonary metastases. Two patients had additional liver metastases, which would not have impacted on the overall management. No patient demonstrated isolated disease below the diaphragm. Conclusion A limited ‘above-diaphragm’ scan for early assessment following chemoradiotherapy may be safely considered. The benefits of this tailored approach flow onto both the health system and the patients as it can improve resource allocation by increasing scanner availability and patient throughput and reduces cumulative patient radiation exposure.
- 1 August 2010
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 35 (8) , 637-639
Ictal SPECT With MRI Fusion Localizing a Seizure Focus in Child With Hemimegalencephaly and Proteus Syndrome
- 1 August 2010
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 35 (8) , 637-639
Ictal SPECT With MRI Fusion Localizing a Seizure Focus in Child With Hemimegalencephaly and Proteus Syndrome
- 15 June 2010
- Published by Wiley in Clinical Cardiology
- Vol. 33 (6) , E106-E108
Positron Emission Tomography Combined With Computed Tomography as an Integral Component in Evaluation of Primary Cardiac Lymphoma
We present a case of primary cardiac lymphoma (PCL) that was initially manifest through syncopal episodes. In the diagnostic evaluation, positron emission tomography combined with computed tomography (PET‐CT) made a significant contribution—beyond that which would have been possible if only conventional imaging modalities such as magnetic resonance imaging (MRI) and transthoracic echocardiography (TTE) were utilized—and played a major role in follow‐up. Copyright
- 15 June 2010
- Published by Wiley in Clinical Cardiology
- Vol. 33 (6) , E106-E108
Positron Emission Tomography Combined With Computed Tomography as an Integral Component in Evaluation of Primary Cardiac Lymphoma
We present a case of primary cardiac lymphoma (PCL) that was initially manifest through syncopal episodes. In the diagnostic evaluation, positron emission tomography combined with computed tomography (PET‐CT) made a significant contribution—beyond that which would have been possible if only conventional imaging modalities such as magnetic resonance imaging (MRI) and transthoracic echocardiography (TTE) were utilized—and played a major role in follow‐up. Copyright
- 1 June 2010
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 35 (6) , 418-420
FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma
- 1 June 2010
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 35 (6) , 418-420
FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma
- 1 May 2010
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 83 (989) , 447-449
An uncommon case of an extra-axial mass
- 1 May 2010
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 83 (989) , 447-449
An uncommon case of an extra-axial mass
- 1 October 2009
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 34 (10) , 710-712
Variable F-18 fluorodeoxyglucose Avidity of Metastatic Recurrent Adult Granulosa Cell Tumor
The appearance of rare ovarian germ cell tumors such as adult granulosa cell tumor (GCT) on F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) is reported in this article. We present a patient with recurrent GCT and histologically proven intra-abdominal metastases. Most lesions were above PET resolution (>1 cm). The local recurrence demonstrated moderate FDG uptake but metastases had variable (none to mild) FDG avidity. Ovarian GCTs are of relatively low metastatic potential and frequently present as metastases with solid and cystic components, which are plausible explanations for its variable FDG uptake. Clinicians should be aware of this phenomenon and the potential for false negatives on FDG-PET.
- 1 October 2009
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 34 (10) , 710-712
Variable F-18 fluorodeoxyglucose Avidity of Metastatic Recurrent Adult Granulosa Cell Tumor
The appearance of rare ovarian germ cell tumors such as adult granulosa cell tumor (GCT) on F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) is reported in this article. We present a patient with recurrent GCT and histologically proven intra-abdominal metastases. Most lesions were above PET resolution (>1 cm). The local recurrence demonstrated moderate FDG uptake but metastases had variable (none to mild) FDG avidity. Ovarian GCTs are of relatively low metastatic potential and frequently present as metastases with solid and cystic components, which are plausible explanations for its variable FDG uptake. Clinicians should be aware of this phenomenon and the potential for false negatives on FDG-PET.
- 1 September 2009
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (11) , 1901
Intractable hiccups causing avid FDG uptake in the muscles of respiration
- 1 September 2009
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (11) , 1901
Intractable hiccups causing avid FDG uptake in the muscles of respiration